Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Multiple Myeloma × Warfarin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1

Interventions

Dexamethasone 97 Bortezomib 54 Cyclophosphamide 46 Lenalidomide 43 Calcium Dobesilate 39 pomalidomide 28 Melphalan 28 fludarabine 23 Filgrastim 22 carfilzomib 20 fludarabine phosphate 17 daratumumab 17 Whole-Body Irradiation 14 Mycophenolic Acid 14 Granulocyte Colony-Stimulating Factor 14 Antilymphocyte Serum 14 dexamethasone acetate 13 Thalidomide 12 Peripheral Blood Stem Cell Transplantation 12 Cyclosporine 12 Tacrolimus 11 Busulfan 11 dexamethasone 21-phosphate 9 auricularum 9 Radiotherapy 9 pembrolizumab 8 belantamab mafodotin 8 Rituximab 8 Etoposide 8 ixazomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00790842 2018-10-24

PrE1003

PrECOG, LLC.

Phase 1/2 Terminated

63 enrolled 14 charts

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡